HCPCS Level IIdrugActive
J9286
Inj glofitamab gxbm, 2.5 mg
BETOS: O1D
Effective: 2024-01-01
Description
Injection, glofitamab-gxbm, 2.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Columvi
Manufacturer
Genentech, Inc.
HCPCS Dosage
2.5 MG
Billing Units
1.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.